Assessment of ropinirole as a reinforcer in rhesus monkeys

Drug and Alcohol Dependence

Volumn 125, Issue 1-2, 2012, Pages 173-177

  Freeman, Kevin B ^a   Heal, David J ^b   McCreary, Andrew C ^c   Woolverton, William L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b RenaSci Ltd   (United Kingdom)

^c CHARLES RIVER LABORATORIES   (United States)

Author keywords

Abuse liability; Cocaine; Monkey; Ropinirole; Self administration

Indexed keywords

ROPINIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DATA INTERPRETATION, STATISTICAL; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; INJECTIONS, INTRAVENOUS; MACACA MULATTA; MALE; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

MACACA MULATTA;

EID: 84865046968     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.04.001     Document Type: Article

References (25)

1. Al-Fulaji M.A., Ren Y., Beinborn M., Kopin A.S. Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function. J. Pharmacol. Exp. Ther. 2007, 321:298-307.
2. Banks M.L., Roma P.G., Folk J.E., Rice K.C., Negus S. Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis. Psychopharmacology (Berl) 2011, 216:431-439.
3. 4 receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 1999, 127:1696-1702.
4. Evans A.H., Lawrence A.D., Pott J., Appel S., Lees A.J. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005, 65:1570-1574.
5. Freeman K.B., Wang Z., Woolverton W.L. Self-administration of (+)-methamphetamine and (+)-pseudoephedrine, alone and combined, by rhesus monkeys. Pharmacol. Biochem. Behav. 2010, 95:198-202.
6. Freeman K.B., Woolverton W.L. Self-administration of cocaine and nicotine by rhesus monkeys. Psychopharmacology (Berl) 2009, 207:99-106.
7. Gardner B., Strange P.G. Agonist action at D2(long) dopamine receptors: ligand binding and functional assays. Br. J. Pharmacol. 1998, 124:978-984.
8. Hansen R.A., Song L., Moore C.G., Gilsenan A.W., Kiim M.M., Calloway M.O., Murray M.D. Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials. Pharmacotherapy 2009, 29:255-262.
9. Hursh S.R., Silberberg A. Economic demand and essential value. Psychol. Rev. 2008, 115:186-198.
10. Johanson C.E., Arfken C.L., Menza S., Schuster C.R. Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians. Drug Alcohol Depend. 2012, 120:1-3.
11. Kulisevsky J., Pagonabarraga J. Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's Disease: meta-analysis of randomized controlled trials. Drug Saf. 2010, 33:147-161.
12. 2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities. Mol. Pharmacol. 1992, 42:432-438.
13. Maremmani A.G.I., Pacini M., Rovai L., Rugani F., Dell'Osso L., Maremmani I. Can ropinirole modulate reinforcing subjective effects of cocaine in humans?. Front. Psychiatry 2011, 2:1-5.
14. Meini M., Moncini M., Cecconi D., Cellesi L., Biasci L., Simoni G., Ameglio M., Pellegrini M., Forgione R.N., Rucci P. Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. Curr. Pharm. Des. 2011, 17:1-8.
15. 3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease. Pharmacol. Ther. 2010, 128:2290-3273.
16. 2 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology (Berl) 1996, 125:13-22.
17. Perugi G., Toni C., Ruffolo G., Frare R., Akiskal H. Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series. Pharmacopsychiatry 2001, 34:137-141.
18. 2 dopamine receptor agonists and partial agonists in rhesus monkeys. Drug Alcohol Depend. 2001, 64:209-217.
19. Riley A.L. The paradox of drug taking: the role of the aversive effects of drugs. Physiol. Behav. 2011, 103:69-78.
20. Samardzic R., Beleslin D.B. Neurochemical mechanisms in area postrema and emesis. Physiol. Pharmacol. Acta 1989, 25(Suppl. 8):133-153.
21. 3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend. 1999, 54:91-110.
22. 3 receptors. Eur. J. Pharmacol. 2011, 666:43-52.
23. 1 agonists in monkeys. J. Pharmacol. Exp. Ther. 1995, 275:1367-1374.
24. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 1984, 230:678-683.
25. Woolverton W.L., Wang Z., Vasterling T., Tallarida R. Self-administration of cocaine-remifentanil mixtures by monkeys: an isobolographic analysis. Psychopharmacology (Berl) 2008, 198:387-394.